Skip to content
Monday, December 2, 2024
Wall Street Insider
Deliver critical advise to busy investors
Search
Search
News
About Us
Services
Institutional Research
Portfolio Analysis
#1 Stock Pick
Subscriptions
Contact Us
CLIENT LOGIN
Home
News
Acadia Pharma’s stock falls 15% after failed drug trial
News
Acadia Pharma’s stock falls 15% after failed drug trial
March 12, 2024
Arthur Bleemer
One of Acadia Pharma’s drugs failed to meet goals of a late-stage trial about a schizophrenia treatment.
Read more from source
Post navigation
Vail Resorts’ stock slips after results, guidance hurt by decline in visits, snowfall
Oracle finally becomes a cloud company, helped by ‘enormous’ AI demand